Would you offer adjuvant abemaciclib + an aromatase inhibitor to a patient with a local HR+HER- breast cancer reoccurrence while on tamoxifen that meets high-risk criteria?   

High-risk criteria meaning >4 positive nodes and Ki67 >20%



Answer from: Medical Oncologist at Academic Institution